CAPRICOR THERAPEUTICS INC (CAPR) Stock Cash Flow
USA - NASDAQ:CAPR - US14070B3096 - Common Stock
5.77 USD
-0.1 (-1.7%)
5.6 USD
-0.17 (-2.95%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -69.98M | -40.47M | -22.29M | -29.02M | -20.02M | |||
| Depreciation Amortization | 1.63M | 1.43M | 1.07M | 530.00K | 250.00K | |||
| Income Taxes - Deferred | undefined | null | null | null | null | |||
| Accounts Payable And Accrued Liabilities | undefined | undefined | undefined | undefined | undefined | |||
| Change In Working Capital | 1.42M | -10.78M | -11.75M | 28.75M | 180.00K | |||
| Interest Paid | 0 | 0 | 0 | 0 | 0 | |||
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | |||
| Other non cash items | 13.94M | 9.83M | 7.37M | 4.65M | 2.79M | |||
| OPERATING CASH FLOW | -52.99M | -40.00M | -25.60M | 4.92M | -16.81M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.38M | -1.54M | -2.05M | -3.36M | -1.20M | |||
| Other Investing Activity | -79.55M | -114.64M | 7.16M | -31.71M | 0 | |||
| INVESTING CASH FLOW | -82.94M | -116.18M | 5.11M | -35.07M | -1.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | undefined | null | null | null | 0 | |||
| Stock Issued/Repurchased | 148.48M | 152.77M | 25.58M | 4.87M | 20.23M | |||
| Dividend Paid | undefined | null | null | null | null | |||
| Other Financing Activity | undefined | null | null | null | null | |||
| FINANCING CASH FLOW | 148.48M | 152.77M | 25.58M | 4.87M | 20.23M | |||
| Exchange Rate Effect | undefined | null | null | null | null | |||
| CHANGE IN CASH | 12.55M | -3.41M | 5.09M | -25.28M | 2.22M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -52.99M | -40.00M | -25.60M | 4.92M | -16.81M | |||
| Capital Expenditure | -3.38M | -1.54M | -2.05M | -3.36M | -1.20M | |||
| FREE CASH FLOW | -56.38M | -41.53M | -27.64M | 1.56M | -18.01M | |||
All data in USD